Literature DB >> 10733240

Correlations between individual clinical manifestations and CTG repeat amplification in myotonic dystrophy.

C Marchini1, R Lonigro, L Verriello, L Pellizzari, P Bergonzi, G Damante.   

Abstract

Myotonic dystrophy (DM) is a multisystemic disease caused by the expansion of a CTG repeat, located in the 3'-untranslated region of the DMPK gene. The number of CTG repeats broadly correlates with the overall severity of the disease. However, correlations between CTG repeat number and presence/absence or severity of individual clinical manifestations in the same patients are yet scarce. In this study the number of CTG repeats detected in blood cells of 24 DM subjects was correlated with the severity of single clinical manifestations. The presence/absence of muscular atrophy, respiratory insufficiency, cardiac abnormalities, diabetes, cataract, sleep disorders, sterility or hypogonadism is not related to the number of CTG repeats. Muscular atrophy and respiratory insufficiency are present with the highest frequency, occurring in 96 and 92% of the cases, respectively. A significant correlation was found with age of onset (r = -0.57, p<0.01), muscular disability (r = 0.46, p<0.05), intellective quotient (r = -0.58, p<0.01) and short-term memory (r= -0.59, p<0.01). Therefore, the CTG repeat number has a predictive value only in the case of some clinical manifestations, this suggesting that pathogenetic mechanisms of DM may differ depending on the tissue.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10733240     DOI: 10.1034/j.1399-0004.2000.570112.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  23 in total

1.  Two children with muscular dystrophies ascertained due to referral for diagnosis of autism.

Authors:  Lonnie Zwaigenbaum; Mark Tarnopolsky
Journal:  J Autism Dev Disord       Date:  2003-04

2.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

3.  Molecular genetic and clinical characterization of myotonic dystrophy type 1 patients carrying variant repeats within DMPK expansions.

Authors:  Jovan Pešović; S Perić; M Brkušanin; G Brajušković; V Rakočević-Stojanović; Dušanka Savić-Pavićević
Journal:  Neurogenetics       Date:  2017-09-23       Impact factor: 2.660

4.  Endocrine function in 97 patients with myotonic dystrophy type 1.

Authors:  M C Ørngreen; P Arlien-Søborg; M Duno; J M Hertz; J Vissing
Journal:  J Neurol       Date:  2012-02-17       Impact factor: 4.849

5.  Identification and characterization of 5' CCG interruptions in complex DMPK expanded alleles.

Authors:  Annalisa Botta; Giulia Rossi; Marzia Marcaurelio; Luana Fontana; Maria Rosaria D'Apice; Francesco Brancati; Roberto Massa; Darren G Monckton; Federica Sangiuolo; Giuseppe Novelli
Journal:  Eur J Hum Genet       Date:  2016-11-23       Impact factor: 4.246

6.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

7.  Response to controlled ovarian stimulation and oocyte quality in women with myotonic dystrophy type I.

Authors:  Banchhita Sahu; Ozkan Ozturk; Nandita Deo; Karen Fordham; Massimo Ranierri; Paul Serhal
Journal:  J Assist Reprod Genet       Date:  2008-01-18       Impact factor: 3.412

8.  Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy.

Authors:  Regina Monteiro; João Bento; Miguel R Gonçalves; Tiago Pinto; João Carlos Winck
Journal:  Sleep Breath       Date:  2013-01-15       Impact factor: 2.816

9.  Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2.

Authors:  Masayuki Nakamori; Krzysztof Sobczak; Richard T Moxley; Charles A Thornton
Journal:  Neuromuscul Disord       Date:  2009-08-26       Impact factor: 4.296

10.  Improved method for molecular diagnosis of myotonic dystrophy type 1 (DM1).

Authors:  Nihan Erginel-Unaltuna; Fahri Akbas
Journal:  J Clin Lab Anal       Date:  2004       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.